Loading...
Impact of CYP2C19 Variants on Clinical Efficacy of Clopidogrel and 1-Year Clinical Outcomes in Coronary Heart Patients Undergoing Percutaneous Coronary Intervention
The impact of pharmacogenetic variants of cytochrome P450 2C19 (CYP2C19) on clopidogrel-mediated effects on platelet inhibition, inflammatory response and endothelial function, as well as risk of major adverse cardiovascular events (MACE), in coronary heart patients undergoing percutaneous coronary...
Saved in:
Published in: | Front Pharmacol |
---|---|
Main Authors: | , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Frontiers Media S.A.
2016
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5121225/ https://ncbi.nlm.nih.gov/pubmed/27932982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00453 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|